New Report Available: Japan Pharmaceuticals & Healthcare Report Q4 2013
An ageing population, coupled with the country's high expenditure on healthcare, makes Japan a very attractive market for drugmakers. We highlight that given Prime Minister Shinzo Abe's aim to revitalise the economy there will potentially be stronger support for research and development, maintaining the country's leadership in the Asia Pacific region. While the ageing population demands more pharmaceutical and medical services, the growth potential of the pharmaceutical market will eventually be limited by its shrinking population.
View full press release